1. Home
  2. SRTA vs IPSC Comparison

SRTA vs IPSC Comparison

Compare SRTA & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SRTA

Strata Critical Medical Inc.

HOLD

Current Price

$6.23

Market Cap

530.4M

Sector

N/A

ML Signal

HOLD

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$2.06

Market Cap

441.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRTA
IPSC
Founded
2014
2019
Country
United States
United States
Employees
601
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
530.4M
441.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SRTA
IPSC
Price
$6.23
$2.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$7.81
$4.25
AVG Volume (30 Days)
1.1M
783.8K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
91.30
EPS
N/A
N/A
Revenue
N/A
$109,164,000.00
Revenue This Year
$39.27
N/A
Revenue Next Year
$8.52
N/A
P/E Ratio
$9.88
N/A
Revenue Growth
N/A
1556.76
52 Week Low
$3.85
$0.44
52 Week High
$6.50
$2.97

Technical Indicators

Market Signals
Indicator
SRTA
IPSC
Relative Strength Index (RSI) 64.36 39.18
Support Level $4.08 $1.87
Resistance Level N/A $2.41
Average True Range (ATR) 0.28 0.15
MACD 0.02 -0.01
Stochastic Oscillator 78.62 2.08

Price Performance

Historical Comparison
SRTA
IPSC

About SRTA Strata Critical Medical Inc.

Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.

Share on Social Networks: